Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
33.49
-0.55 (-1.62%)
Mar 6, 2026, 9:36 AM EST - Market open
Corcept Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 761.41 | 675.04 | 482.38 | 401.86 | 365.98 | Upgrade
|
| Revenue Growth (YoY) | 12.79% | 39.94% | 20.04% | 9.80% | 3.42% | Upgrade
|
| Cost of Revenue | 12.98 | 10.88 | 6.48 | 5.39 | 5.28 | Upgrade
|
| Gross Profit | 748.43 | 664.16 | 475.89 | 396.47 | 360.7 | Upgrade
|
| Selling, General & Admin | 448.73 | 280.32 | 184.26 | 152.85 | 122.36 | Upgrade
|
| Research & Development | 254.91 | 246.89 | 184.35 | 130.99 | 113.86 | Upgrade
|
| Operating Expenses | 703.63 | 527.21 | 368.61 | 283.84 | 236.22 | Upgrade
|
| Operating Income | 44.8 | 136.95 | 107.28 | 112.63 | 124.48 | Upgrade
|
| Interest & Investment Income | 21.67 | 24.54 | 17.28 | 3.56 | 0.53 | Upgrade
|
| Legal Settlements | - | - | - | -14 | - | Upgrade
|
| Pretax Income | 66.46 | 161.49 | 124.56 | 116.19 | 125.01 | Upgrade
|
| Income Tax Expense | -33.19 | 20.28 | 18.42 | 14.77 | 12.49 | Upgrade
|
| Net Income | 99.65 | 141.21 | 106.14 | 101.42 | 112.51 | Upgrade
|
| Preferred Dividends & Other Adjustments | 1.48 | 1.48 | 0.64 | 0.13 | - | Upgrade
|
| Net Income to Common | 98.17 | 139.73 | 105.5 | 101.29 | 112.51 | Upgrade
|
| Net Income Growth | -29.43% | 33.04% | 4.66% | -9.86% | 6.13% | Upgrade
|
| Shares Outstanding (Basic) | 104 | 103 | 104 | 107 | 116 | Upgrade
|
| Shares Outstanding (Diluted) | 120 | 113 | 112 | 116 | 126 | Upgrade
|
| Shares Change (YoY) | 5.73% | 1.55% | -3.64% | -7.94% | 1.42% | Upgrade
|
| EPS (Basic) | 0.95 | 1.35 | 1.02 | 0.95 | 0.97 | Upgrade
|
| EPS (Diluted) | 0.82 | 1.23 | 0.94 | 0.87 | 0.89 | Upgrade
|
| EPS Growth | -33.33% | 30.85% | 8.05% | -2.25% | 4.71% | Upgrade
|
| Free Cash Flow | 141.79 | 196.12 | 126.54 | 119.91 | 167.42 | Upgrade
|
| Free Cash Flow Per Share | 1.18 | 1.73 | 1.13 | 1.03 | 1.33 | Upgrade
|
| Gross Margin | 98.30% | 98.39% | 98.66% | 98.66% | 98.56% | Upgrade
|
| Operating Margin | 5.88% | 20.29% | 22.24% | 28.03% | 34.01% | Upgrade
|
| Profit Margin | 12.89% | 20.70% | 21.87% | 25.20% | 30.74% | Upgrade
|
| Free Cash Flow Margin | 18.62% | 29.05% | 26.23% | 29.84% | 45.75% | Upgrade
|
| EBITDA | 45.95 | 137.75 | 108.32 | 113.89 | 125.96 | Upgrade
|
| EBITDA Margin | 6.03% | 20.41% | 22.46% | 28.34% | 34.42% | Upgrade
|
| D&A For EBITDA | 1.15 | 0.8 | 1.04 | 1.26 | 1.48 | Upgrade
|
| EBIT | 44.8 | 136.95 | 107.28 | 112.63 | 124.48 | Upgrade
|
| EBIT Margin | 5.88% | 20.29% | 22.24% | 28.03% | 34.01% | Upgrade
|
| Effective Tax Rate | - | 12.56% | 14.79% | 12.71% | 9.99% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.